ExpertAsia-improving patient outcomes - Introducing PCDx - targeted diagnostics for oncology patients

This molecular analysis provides a broad-spectrum analysis covering 186 alterations tested, with over 500 nucleotides of interest including NGS for DNA mutations, DNA copy number variation, mRNA expression, fusions and isoforms and protein by IHC. PCDx is developed and driven by supporting data and literature and provides the most therapeutic associations of any profiling service currently available on the market.


PCDx Clinical Evidence Engine
PCDx Clinical Evidence Engine
The PCDx test identifies actionable classes of genomic alterations in hundreds of cancer-related genes, including the following.
This advanced diagnostic tool is now available in the Philippines via ExpertAsia Marketing Consulting & Services Ltd.


Website Builder provided by  Vistaprint